HomeQuestion

What is your approach to addressing comorbidities that influence asthma severity?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?

When do you consider switching from another biologic to benralizumab in patients with severe eosinophilic asthma with a history of suboptimal response to previous biologic agents?

Should thunderstorm asthma be incorporated into asthma action plans?

In patients with severe asthma who are candidates for biologics, do you put them on an ICS/LABA/LAMA rather than high dose ICS/LABA?

Among paralyzed, volume- or pressure-controlled ventilated adults with refractory status asthmaticus, should extrinsic PEEP be routinely applied, minimized (e.g., 0–5 cm H₂O), or titrated (e.g., to ~75–80% of measured auto-PEEP)?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.